An Observational Study of People Who Have Recently Been Infected With HIV
Primary HIV & Early Disease Research: American Cohort (PHAEDRA) AIEDRP
2 other identifiers
observational
500
1 country
2
Brief Summary
This is a long-term follow-up study of people who are identified during acute or recent HIV infection and are being followed at clinical research sites associated with the Acute HIV Infection and Early Disease Research Program (AIEDRP). The purpose of this study is to collect data on the immunological and virologic responses that occur early in the course of HIV infection in treatment-naive and treatment-experienced HIV infected adults. Study hypothesis: This study will examine the immunological responses that occur early in the course of HIV infection in treated and untreated individuals. The long-term follow-up of these subjects will help identify host immunological and genetic factors along with therapeutic strategies associated with control of viremia and delayed disease progression. In addition, this cohort will provide the recruiting mechanism to support future trials of therapy to restore immune function. Furthermore, this cohort will provide a population suitable to monitoring changing patterns in the transmission of drug resistant viral strains while also evaluating ongoing behavioral risk factors associated with HIV transmission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2004
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
February 17, 2005
CompletedFirst Posted
Study publicly available on registry
February 18, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedNovember 28, 2018
September 1, 2008
3.8 years
February 17, 2005
November 27, 2018
Conditions
Keywords
Study Arms (1)
1
Treatment-naive and treatment-experienced HIV-infected adults
Interventions
Eligibility Criteria
Treatment-naive and treatment-experienced HIV-infected adults
You may qualify if:
- Documented acute or recent HIV infection as defined in the study protocol
- Willing to be followed longitudinally by this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
Related Links
Biospecimen
Blood collection
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Rosenberg, MD
Partners Healthcare, Massachusetts General Hospital
- PRINCIPAL INVESTIGATOR
Bruce D. Walker, MD
Partners Healthcare, Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
February 17, 2005
First Posted
February 18, 2005
Study Start
January 1, 2004
Primary Completion
October 1, 2007
Study Completion
December 1, 2014
Last Updated
November 28, 2018
Record last verified: 2008-09